Apeiron Capital Limited
http://www.apeiron.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Apeiron Capital Limited
Pipeline Watch: Phase III Starts With Simvastatin, AR101 And Brexanolone
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
CHMP’s March Recommendations Include Dinutuximab, Nonacog Beta Pegol And Trumenba
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) meets monthly to review applications for centralized EU marketing authorization. Here’s a summary of their March 2017 recommendations.
Company Information
- Industry
- Miscellaneous
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Apeiron Capital Limited
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice